Portland, OR -- (SBWIRE) -- 07/06/2017 -- Enteric disease is a condition caused in the intestine due to the presence of foreign antigen such as bacterial, viral and parasites. The enteric diseases are commonly caused due to E-coli, Vibro Cholerae salmonella, shigella, rotavirus, and norovirus. The most influencing factor being hygiene is getting worst due to the increasing population, especially in urban areas of developing economies. Several factors such as unsafe drinking water, poor sanitation and unhygienic conditions are increasing the prevalence of enteric diseases. In order to overcome the severity of these diseases, the companies are shifting their trends from conventional to more advance diagnostics and treatments. The companies are adopting various strategies for the development of novel therapeutics and testing technologies for enteric diseases. The report analyzes these key strategies of leading players. Government regulation and reimbursement scenarios for the enteric disease are dealt according to geographies. The enteric disease testing market external environment has been studied in order to provide intelligence to decision markers.
Early buyers will receive 20% customization on this report.
The market enteric disease testing market is hindered due to high cost of equipments and labors, and mandatory requirement for sophisticated laboratory conditions for clinical diagnostics. These challenges are expected to be resolve in future with the emergence of various advance cost effective technologies such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR). Furthermore, increase in intervention from the governments to improve the living standard in people is expected to influence the market positively. The government authorities are chiefly responsible for shifting the trend of conventional diagnostic to advance methods.
Global Enteric Disease Testing Therapeutics Market
Global enteric disease testing therapeutics market is segmented into Campylobacter, Cryptosporidium, E-Coli, Enteroviruses, RhinoViruses, RotaVirus (REOVIRUS), Salmonellosis and Shigellosis. E-coli is the leading bacteria that cause the enteric disorders among children.
Get PDF of this Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/295
Global Enteric Disease Testing Technology Market
Global enteric disease testing technology market is segmented into, Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, Differential Light Scattering, Information Technology, Artificial Intelligence, Liposomes, Flow Cytometry, Chromatography , Diagnostic Imaging, Gel Microdroplets and Others. The molecular diagnostics is the emerging technology in enteric diseases and it is expected to be the fastest growing compared to other technologies.
Global Enteric Disease Geography Testing Market
Global enteric disease testing market by geography is segmented into North America, Europe, Asia-Pacific and LAMEA. Asia-Pacific is currently dominating the market with more than 50% of market share. This is due to increase in migration of people from rural areas to urban.
Competitive Landscape
Key players operating in testing and therapeutics market are adopting product launch and approval for the commercialization of novel technologies. These companies are investing in research and development to advance the testing technologies in order to increase the efficiency of diagnosis. Key companies included in the report are Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., Biomerieux, Bio-Rad, Cepheid Coris Bioconcept, Diasorin, Meridian Bioscience, Inc, Quest Diagnostics and Trinity Biotech.
High Level Analysis
Enteric Disease Testing Market is an emerging market that has accelerated the growth of rapid diseases diagnosis for enteric diseases. These technologies are strategically analyzed in the report in order to provide comparative benefits. The report is also concentrating on the regulatory issues that are hindering the growth. Porter's five force model is strategically dealt in the report to project the market trends. The value chain analysis of the Enteric Disease Testing Market is dealt strategically. Top investment pocket for Enteric Disease Testing technology market show the impact of growth factors. Top wining strategies adopted by the key players competing in this market are critically analyzed through primaries.
Key Benefits
-Identification of key investment pockets for enteric disease testing technology market would help in providing strategic assistance to decision markers
-Analysis of key market players and strategies adopted by them are dealt to give a deep dive intelligence on top contenders in the market
-This report gives a detailed analysis of drivers and factors limiting market expansion of Enteric Disease Testing Market
-Projections are made for the next eight years by considering values of 2012 as reference
-Porter's five forces and SWOT analysis discussed would help in making strategic decisions
Key Deliverables
The global Enteric Disease Testing Market is segmented into testing types, technologies and geography.
MARKET BY THERAPEUTICS
-Campylobacter
-Cryptosporidium
-E-Coli
-Enteroviruses
-RhinoViruses
-RotaVirus (REOVIRUS)
-Salmonellosis
-Shigellosis
MARKET BY TECHNOLOGIES
-Molecular Diagnostics
-Monoclonal Antibodies
-Immunoassays
-Differential Light Scattering
-Information Technology
-Artificial Intelligence
-Liposomes
-Flow Cytometry
-Chromatography
-Diagnostic Imaging
-Gel Microdroplets
-Others
MARKET BY GEOGRAPHY
-North America
-Europe
-Asia-Pacific
-LAMEA